1. Wegner, Marthe-Susanna, Gruber, Lisa, Mattjus, Peter, Geisslinger, Gerd, Grösch, Sabine. 2018. The UDP-glucose ceramide glycosyltransferase (UGCG) and the link to multidrug resistance protein 1 (MDR1). In BMC cancer, 18, 153. doi:10.1186/s12885-018-4084-4. https://pubmed.ncbi.nlm.nih.gov/29409484/
2. Schömel, Nina, Hancock, Sarah E, Gruber, Lisa, Geisslinger, Gerd, Wegner, Marthe-Susanna. 2019. UGCG influences glutamine metabolism of breast cancer cells. In Scientific reports, 9, 15665. doi:10.1038/s41598-019-52169-7. https://pubmed.ncbi.nlm.nih.gov/31666638/
3. Fan, Wenjie, Yao, Chen, Ma, Yanjie, Yang, Guoyu, Wang, Mengdi. 2024. Inhibiting UGCG prevents PRV infection by decreasing lysosome-associated autophage. In International journal of biological macromolecules, 285, 138303. doi:10.1016/j.ijbiomac.2024.138303. https://pubmed.ncbi.nlm.nih.gov/39631580/
4. Byrne, Frances L, Olzomer, Ellen M, Lolies, Nina, Hoehn, Kyle L, Wegner, Marthe-Susanna. 2022. Update on Glycosphingolipids Abundance in Hepatocellular Carcinoma. In International journal of molecular sciences, 23, . doi:10.3390/ijms23094477. https://pubmed.ncbi.nlm.nih.gov/35562868/
5. Schömel, Nina, Gruber, Lisa, Alexopoulos, Stephanie J, Geisslinger, Gerd, Wegner, Marthe-Susanna. 2020. UGCG overexpression leads to increased glycolysis and increased oxidative phosphorylation of breast cancer cells. In Scientific reports, 10, 8182. doi:10.1038/s41598-020-65182-y. https://pubmed.ncbi.nlm.nih.gov/32424263/